UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

A Phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in Patients with solid malignancies

Clinical cancer research, 2002, Vol.8 (1), p.75-85

2002

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1

The lancet oncology, 2009-05, Vol.10 (5), p.508-515

2009

Link zum Volltext

Verfügbarkeit prüfen

Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors

Genes chromosomes & cancer, 2011-12, Vol.50 (12), p.1021-1032

2011

Link zum Volltext

Verfügbarkeit prüfen

Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas

Gynecologic oncology, 2013-11, Vol.131 (2), p.410-415

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies

Cancer Immunology, Immunotherapy, 2007-03, Vol.56 (3), p.303-317

2007

Link zum Volltext

Verfügbarkeit prüfen

Secretory Leukocyte Protease Inhibitor in Cancer Development

Annals of the New York Academy of Sciences, 2004-12, Vol.1028 (1), p.380-389

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel

Anti-cancer drugs, 2001-04, Vol.12 (4), p.315-323

2001

Link zum Volltext

Verfügbarkeit prüfen

Coadministration of Oral Cyclosporin A Enables Oral Therapy with Paclitaxel

Clinical cancer research, 1999-11, Vol.5 (11), p.3379-3384

1999

Link zum Volltext

Verfügbarkeit prüfen

Increased Oral Bioavailability of Paclitaxel by GF120918 in Mice through Selective Modulation of P-glycoprotein

Clinical cancer research, 2000-11, Vol.6 (11), p.4416-4421

2000

Link zum Volltext

Verfügbarkeit prüfen

Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physicians

Breast cancer research and treatment, 2012-10, Vol.135 (3), p.811-820

2012

Link zum Volltext

Verfügbarkeit prüfen

Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patients

Genes chromosomes & cancer, 2006-10, Vol.45 (10), p.893-904

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase I and Pharmacokinetic Study of Oral Paclitaxel

Journal of clinical oncology, 2000-06, Vol.18 (12), p.2468-2475

2000

Link zum Volltext

Verfügbarkeit prüfen

Metabolism of trabectedin (ET-743, Yondelis™) in patients with advanced cancer

Cancer chemotherapy and pharmacology, 2007-06, Vol.59 (6), p.825-837

2007

Link zum Volltext

Verfügbarkeit prüfen

Monitoring of disseminated tumor cells in bone marrow in high‐risk breast cancer patients treated with high‐dose chemotherapy

International journal of cancer, 2006-06, Vol.118 (11), p.2877-2881

2006

Link zum Volltext

Verfügbarkeit prüfen

CD4+ T cells kill Id+ B-lymphoma cells: Fasligand-fas interaction is dominant in vitro but is redundant in vivo

Cancer Immunology, Immunotherapy, 2004-12, Vol.53 (12), p.1135-1145

2004

Link zum Volltext

Verfügbarkeit prüfen

A DNA probe combination for improved detection of MLL/11q23 breakpoints by double-color interphase-FISH in acute leukemias

Genes chromosomes & cancer, 2000-05, Vol.28 (1), p.14-22

2000

Link zum Volltext

Verfügbarkeit prüfen

A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A

Cancer chemotherapy and pharmacology, 2001-04, Vol.47 (4), p.347-354

2001

Link zum Volltext

Verfügbarkeit prüfen

Urinary and fecal excretion of topotecan in patients with malignant solid tumours

Cancer chemotherapy and pharmacology, 2002-07, Vol.50 (1), p.59-64

2002

Link zum Volltext

Verfügbarkeit prüfen

FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia

Genes chromosomes & cancer, 1998-06, Vol.22 (2), p.87-94

1998

Link zum Volltext

Verfügbarkeit prüfen

Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair

Cancer letters, 2021-05, Vol.505, p.1-12

2021

Link zum Volltext

Verfügbarkeit prüfen

SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma

Oncogene, 2014-10, Vol.33 (42), p.5006-5016

2014

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D: is it important in haematopoietic stem cell transplantation? A review

Bone marrow transplantation (Basingstoke), 2019-06, Vol.54 (6), p.810-820

2019

Link zum Volltext

Verfügbarkeit prüfen

Plasma IL-1 and IL-6 Family Cytokines with Soluble Receptor Levels at Diagnosis in Head and Neck Squamous Cell Carcinoma: High Levels Predict Decreased Five-Year Disease-Specific and Overall Survival

Cancers, 2024-04, Vol.16 (8), p.1484

2024

Link zum Volltext

Verfügbarkeit prüfen

A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease

PloS one, 2012-12, Vol.7 (12), p.e51892

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

SpracheFranzösisch

ThemaArts & Humanities

PublikationsformArtikel

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(52)

Sprache

Englisch
(37)
Deutsch
(16)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A Phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in Patients with solid malignancies

Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1

Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors

Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas

Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies

Secretory Leukocyte Protease Inhibitor in Cancer Development

Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel

Coadministration of Oral Cyclosporin A Enables Oral Therapy with Paclitaxel

Increased Oral Bioavailability of Paclitaxel by GF120918 in Mice through Selective Modulation of P-glycoprotein

Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physicians

Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patients

Phase I and Pharmacokinetic Study of Oral Paclitaxel

Metabolism of trabectedin (ET-743, Yondelis™) in patients with advanced cancer

Monitoring of disseminated tumor cells in bone marrow in high‐risk breast cancer patients treated with high‐dose chemotherapy

CD4+ T cells kill Id+ B-lymphoma cells: Fasligand-fas interaction is dominant in vitro but is redundant in vivo

A DNA probe combination for improved detection of MLL/11q23 breakpoints by double-color interphase-FISH in acute leukemias

A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A

Urinary and fecal excretion of topotecan in patients with malignant solid tumours

FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial

Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair

SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma

Vitamin D: is it important in haematopoietic stem cell transplantation? A review

Plasma IL-1 and IL-6 Family Cytokines with Soluble Receptor Levels at Diagnosis in Head and Neck Squamous Cell Carcinoma: High Levels Predict Decreased Five-Year Disease-Specific and Overall Survival

A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease

Aktive Filter

Suchergebnisse filtern